{
  "total_facts": 5,
  "average_quality_score": 82.0,
  "estimated_precision": 1.0,
  "results": [
    {
      "fact": {
        "drug_name": "citalopram",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": "remission rate",
        "side_effects": [],
        "effect_size": "",
        "confidence_interval": "",
        "source_id": "Psychiatry",
        "section": "Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report",
        "span": "A total of 2,876 adult outpatients with major depressive disorder, enrolled from 18 primary and 23 psychiatric care sites, received citalopram in Level 1 of STAR*D.",
        "confidence": 0.9
      },
      "quality_score": 80.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 80,
          "likely_correct": true,
          "issues": [
            "Span doesn't contain typical TREATS language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "citalopram",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": "symptom remission",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Psychiatry",
        "section": "Intervention",
        "span": "The aim of citalopram treatment in Level 1 was to achieve symptom remission, which was defined as QIDS-C score \u2264 5.",
        "confidence": 0.9
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "citalopram",
        "condition_name": "depression",
        "relation": "IMPROVES",
        "outcome": "HAM-D score",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Psychiatry",
        "section": "Main Outcome Measures",
        "span": "The primary outcome measure was the HAM-D score, obtained by research outcome assessors using telephone-based structured interviews at entry and exit from citalopram treatment.",
        "confidence": 0.9
      },
      "quality_score": 70.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 70,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span",
            "Span doesn't contain typical IMPROVES language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "citalopram",
        "condition_name": "depression",
        "relation": "IMPROVES",
        "outcome": "remission rate",
        "side_effects": [],
        "effect_size": "lower remission rates compared to nonanxious depression",
        "confidence_interval": null,
        "source_id": "Psychiatry",
        "section": "discussion",
        "span": "patients with anxious depression were less likely to respond or to remit with citalopram treatment than those with nonanxious depression",
        "confidence": 0.9
      },
      "quality_score": 80.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 80,
          "likely_correct": true,
          "issues": [
            "Span doesn't contain typical IMPROVES language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "citalopram",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": "remission",
        "side_effects": [
          "worsening insomnia",
          "nervousness",
          "dryness of mouth",
          "constipation"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Psychiatry",
        "section": "Patient Perspective",
        "span": "Ms. D was started on a course of antidepressant therapy with citalopram... After 6 weeks of combined treatment with citalopram and a benzodiazepine, Ms. D reported a significant improvement in all her symptoms, and remission was achieved at the end of the 10th week of treatment.",
        "confidence": 0.9
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    }
  ]
}